Indication

Testicular germ cell tumor

A testicular germ cell tumor is a malignancy originating from the sperm-producing germ cells of the male reproductive system, representing over 90% of all primary testicular cancers. Read more about Testicular germ cell tumor

41 drugs 22 manufacturers

Advertisement

Drugs that treat it

Common Testicular germ cell tumor therapies.

Showing 37–41 of 41 drugs

CISPLATIN

PLATINUM COMPOUNDS·OVARIAN GERM CELL TUMOR CARCINOMA·+5
FOSUN PHARMA US

IFOSFAMIDE

NITROGEN MUSTARD DERIVATIVES·TESTICULAR GERM CELL TUMOR
FRESENIUS KABI

CISPLATIN

PLATINUM COMPOUNDS·OVARIAN GERM CELL TUMOR CARCINOMA·+5
FRESENIUS KABI

IFOSFAMIDE

NITROGEN MUSTARD DERIVATIVES·TESTICULAR GERM CELL TUMOR
STERIMAX INC.
Filter & compare in the drug finder →Opens the drug finder with Testicular germ cell tumor preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Testicular germ cell tumor.

A testicular germ cell tumor is a malignancy originating from the sperm-producing germ cells of the male reproductive system, representing over 90% of all primary testicular cancers.

It most commonly affects adolescent and young adult males between 15 and 35 years of age and typically manifests clinically as a painless, firm scrotal mass or swelling.

Pathophysiologically, these neoplasms are categorized into two primary histological groups: seminomas, which often exhibit slower growth and marked radiosensitivity, and nonseminomatous germ cell tumors, which encompass embryonal carcinoma, teratoma, yolk sac tumor, and choriocarcinoma.

Definitive clinical management and staging frequently involve serum tumor marker evaluation, including alpha-fetoprotein, beta-human chorionic gonadotropin, and lactate dehydrogenase.

Personalize your experience

Follow Testicular germ cell tumor and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it